Author:
Langer Astrid,Rogowski Wolf
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Allenet B, Paree F, Lebrun T, Carr L, Posnett J, Martini J, Yvon C: Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. Diabetes Metab. 2000, 26 (2): 125-132.
2. Ho C, Tran K, Hux M, Sibbald G, Campbell K: Artificial skin grafts in chronic wound care: A meta-analysis of clinical efficacy and a review of cost-effectiveness. Technology Report. 2005, Ottawa: CCOHTA, 52.
3. Evers S, Goossens M, Vet H, van Tulder M, Ament A: Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care. 2005, 21 (2): 240-245.
4. Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacott N, Glanville J: A review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004, 8 (36): iii-iv, ix-xi-1-158.
5. Persson U, Willis M, Odegaard K, Apelqvist J: The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data. Value Health. 2000, 3 (Suppl 1): 39-46. 10.1046/j.1524-4733.2000.36027.x.
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献